Newron Pharmaceuticals S.p.A. (NWRN.SW) SIX

23.65

+0.8(+3.50%)

Updated at December 23 05:31PM

Currency In CHF

Valuation

Market Cap176.72M
Enterprise Value220.26M
P/E Ratio20.11
PEG Ratio0.34
Price/Sales Ratio8.5
Price/Book Ratio321.93
Enterprise/Revenue8.94
Enterprise/EBITDA15.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.42
Operating Margin0.59

Management Effectiveness

Return On Assets0.41
Return On Equity16.66

Income Statement

Revenue51.39M
Revenue/Share3
Gross Profit51.39M
EBITDA25.94M
Net Income15.84M
Diluted EPS0.85

Balance Sheet

Total Cash43.2M
Total Cash/Share2.16
Total Debt52.57M
Total Debt/Equity33.23
Current Ratio1.51
Book Value Per Share0.08

Price History

52-Week Change168.14
52-Week High24
52-Week Low5.2
Moving Average 50 Days16.79
Moving Average 200 Days10.33

Statistics

Average Volume149,331
Shares Outstanding19.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A